Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
preprint
OA: closed
Abstract
Mosquito allergy can rarely give raise to severe clinical manifestations.Here we describe the case of a patient suffering from relapsing anaphylaxis after mosquito bites, who completely responded to off label therapy with anti-IgE monoclonal antibody.This is the first demonstration of the efficacy of omalizumab in such unusual life-threatening allergy.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00